Professor Frédéric (Fred) Hollande is Deputy Head at the Department of Clinical Pathology, University of Melbourne, and a group leader at the University of Melbourne Centre for Cancer Research. He’s also behind the image recognised in the Science to Art NHMRC Biennial Award.
2021 ANSTO Eureka Prize for Innovative Use of Technology
Developing an early warning system to predict fatal respiratory viral infection outcomes.
University of Adelaide's Professor Ian Olver received the 2021 NHMRC Ethics Award in recognition of his significant contribution to Australian health and medical research ethics over the last decade. As chair of NHMRC’s Australian Health Ethics Committee, and as a valued member of NHMRC Council from 2012 to 2018, his balanced and considered leadership style and willingness to engage sensitively on tough issues supported a wider understanding of the ethical impact of emerging health and medical research innovations and technologies.
Drugs already approved and available could be the answer to boost the production of killer T cells and improve the success rate of immunotherapies for cancer.
Associate Professor Joshua Vogel is a Principal Research Fellow at the Burnet Institute in Melbourne, where he co-heads the Global Women’s and Newborn’s Health Group. His research focuses on addressing maternal and perinatal health issues affecting women and families in limited-resource settings. Associate Professor Vogel was the winner of the 2020 Peter Doherty Investigator Grant Award, and the Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.
Hepatitis B is an infectious disease that causes the liver to become inflamed and contributes to increasing rates of liver cancer in Australia and globally.
The daily burden of living with diabetes can be significant. It’s estimated that people with diabetes face up to 180 diabetes-related decisions every day. That’s more than 65,000 extra decisions a year. These decisions can range from managing daily blood sugar levels, food intake and exercise to the management of serious diabetes complications.
Having experienced two Indigenous internships with NHMRC, Vernon Armstrong has now started his journey in mental health research.
A diamond-enriched smart dressing made of silk that enables doctors to read the chemistry of an infected or healing wound could be the answer to more effective therapies, particularly for burns.
Professor Erica Wood is head of the Transfusion Unit at Monash University. Her research describes how blood is used in Australia, and how its use can be improved and made safer and more cost-effective. Through registry data and clinical trials, and studies of novel blood products, Professor Wood and her team aim to improve access and transfusion outcomes for patients.
As one of NHMRC’s first Indigenous Interns, Nada Powell is about to embark on her next journey which is likely to now include research.
Professor John Bekkers from the John Curtin School of Medical Research and his team are currently working on the neurons and circuits in the brain that underlie the sense of smell. His team focus on the olfactory cortex, a brain region that is responsible for our ability to recognise and remember odours.
Professor Kate Conigrave from The University of Sydney is an Addiction Medicine Specialist and Public Health Physician based at Royal Prince Alfred Hospital. Her work combines treating individuals with alcohol, drug and tobacco problems; promoting the health of communities and research and teaching. She is currently the chair of the NHMRC's Alcohol Working Group, which is charged with reviewing the guidelines to reduce the health risks from drinking alcohol.
Professor Rachelle Buchbinder is an NHMRC Senior Principal Research Fellow. She is the Director and Professor in the Monash University Department of Epidemiology & Preventive Medicine since 2007.
Dr Jeanette Tamplin from The University of Melbourne is using therapeutic singing groups to support people living with dementia.
Associate Professor Antony Cooper from the Garvan Institute of Medical Research is a cell and molecular biologist / geneticist with strong interests in elucidating how cellular dysfunction results in human diseases, with a specific interest in neurodegenerative disease such as Parkinson’s Disease.
Professor Mark Dawson is a clinician-scientist at the Peter MacCallum Cancer Centre, meaning he both treats blood cancer patients and leads cutting-edge cancer research in the lab.
Professor Jo Salmon from the Institute for Physical Activity and Nutrition (IPAN), Deakin University received the Elizabeth Blackburn Investigator Grant Award at last year’s NHMRC Research Excellence Awards. Her research focuses on how to effectively implement physical activity interventions at scale across the population, particularly in children. Physical inactivity is a leading modifiable risk factor for childhood obesity and other physical and mental health conditions.
The formation of abnormal proteins in the brain has long been suspected to contribute to the development of Alzheimer’s disease and other neurodegenerative diseases. Yet many individuals with abnormal protein formations do not go on to develop such diseases.
Professor Mark Willcox from the University of New South Wales received the Marshall and Warren Ideas Grant Award at this year’s NHMRC Research Excellence Awards. Professor Willcox’s research targets hospital-acquired infections. Half of all hospital-acquired infections are from microbial colonisation of medical devices such as catheters and hip replacements. Professor Willcox and his team are developing new antimicrobial coatings that can be applied to medical devices to reduce the incidence of these infections.
APPRISE is the Australian Partnership for Preparedness Research on Infectious Disease Emergencies. It was established in 2016 with an investment of $5 million funded by NHMRC and an additional $2 million in 2020 to undertake a range of studies to inform the public health and clinical responses to the COVID-19 outbreak.
Over the past 20 years, NHMRC has invested more than $23 million in 37 projects on pandemic preparedness.
Professor Sandra Eades from Curtin University has dedicated her career to research in Aboriginal health improvements. Professor Eades works with NHMRC to advise and develop strategic guidelines focused on closing the gap.
Associate Professor James St John from Griffith University received the Marshall and Warren Innovation Award at the 2020 NHMRC Research Excellence Awards. His research involves the development of cell transplantation therapies to repair the nervous system, particularly peripheral nerve and spinal cord injuries.
Associate Professor Jaqui Hughes from the Menzies School of Health Research received the 2019 NHMRC Clinical Trials and Cohort Studies Award at NHMRC’s Research Excellence Awards ceremony in March 2020. Kidney disease is a significant health priority among Aboriginal and Torres Strait Islander communities. The cohort study being led by A/Professor Hughes will describe the long-term changes in kidney function over 10 years. This will provide critical data to inform regional and national policy on identification and care of people with kidney disease.
Professor Glenda Halliday from the University of Sydney’s Faculty of Medicine and Health and the Brain and Mind Centre received NHMRC’s Elizabeth Blackburn Investigator Grant Award at this year’s NHMRC Research Excellence Awards. Her research aims to identify and understand the pathobiology of non-Alzheimer dementias and degenerative motor syndromes. These syndromes are currently under-recognised, mainly affect people in their prime, can kill rapidly, and have no mechanistic therapies.
Professor Louisa Jorm is the Foundation Director of the Centre for Big Data Research in Health at UNSW Sydney.
Professor Carola Vinuesa is a Professor of Immunology at the Australian National University and Head of the Pathogens and Immunity Department. She discusses Cellular Immunology and how blue sky research impacts human health.
NHMRC caught up with Professor Andrew Lloyd from The University of New South Wales who develops vaccines for Hepatitis C, which effects 750,000 Australians.
Developing better understanding of effective therapeutic practices with Aboriginal clients, in Aboriginal community settings, and with Aboriginal practitioners, across the spectrum of mental health and social and emotional wellbeing outcomes is the goal of Dr Graham Gee.
Professor David Grayden is in the department of biomedical engineering at the University of Melbourne.
Prof Si Ming Man from The Australian National University and his team investigates the role of innate immunity in infectious diseases and cancer. Professor Ming Man received the NHMRC Research Excellence Award for the highest-ranked Early Career Fellowship (2015) and an NHMRC Research Excellence Award for the highest-ranked Career Development Fellowship Biomedical Level 1 (2019). He also received the 2019 Commonwealth Health Minister's Medal for Excellence in Health and Medical Research and the 2021 CSL Centenary Fellowship.
Professor Joanne Reed from the Garvan Institute's research focuses on autoimmune diseases, particularly the origin and role of autoantibodies.
Could an antiseptic mouthwash reduce sexually transmitted infections and improve the sex life of Australians?
The 2020 Commonwealth Health Minister's Award for Excellence in Health and Medical Research has been awarded to Associate Professor Eric Chow of Monash University. The award has been presented each year since 2000 and recognises the top-ranked recipient of a National Health and Medical Research Council Investigator Grant in the Emerging Leadership Level 2 category from the previous year’s application round.
Dr. Clara Chow is Professor of Medicine, Faculty of Medicine and Health, Academic Director of the Westmead Applied Research Centre and Academic Co-Director of CPC Westmead. She is a NHMRC Investigator Grant Leadership awardee and with this leads a research program focused on innovation for health service provision and clinical management of cardiovascular disease prevention.
Dr David Gonsalvez heads up a laboratory focused on how glia, the non-neuronal cells in the brain and spinal cord, develop, contribute to neuronal plasticity and respond following injury.
“What I really like about the NHMRC system is that it is a fantastic scheme for women in science.”
In 2016 Associate Professor Leonie Quinn relocated to The John Curtin School of Medical Research (ANU, Canberra) to establish the Quinn Group - Cancer Models in the ACRF Department of Cancer Biology and Therapeutics.
Professor Julie Bines from Murdoch Children's Research Institute is doing some inspiring work, developing the RV3-BB rotavirus vaccine.
Almost $400 million in world-leading health and medical research projects to improve the lives of all Australians.
The Investigator Grant scheme is NHMRC’s flagship scheme, developed as part of a major reform of NHMRC’s grant program. This is the second round of Investigator Grants to be awarded. A total of 237 leading researchers across all career stages will receive five-year Investigator Grants from the National Health and Medical Research Council.
Over 275 intensive care units in 15 countries are trialling more than 33 pneumonia treatments to save the lives of critically ill COVID-19 patients. The trial, REMAP-CAP, is an adaptive clinical trial built to deliver fast results in a pandemic and is now one of three key national trials identified by the UK government.
Professor Hannan from the John Curtin School of Medical Research is an internationally recognised laboratory scientist, whose work on ribosome biogenesis has led to new treatment paradigms in cancer, centred on drugs that activate nucleolar stress.
Professor Emily Banks is focused on those unanswered questions around prevention to really make a difference.
Coeliac disease is a common autoimmune-like illness caused by gluten. The condition affects over 350,000 Australians, causing substantial morbidity, impaired quality of life and increased health care costs.
Glaucoma is a leading cause of irreversible blindness worldwide, with an estimated 80 million people predicted to be affected by 2020.
Medication errors are widely recognised as a major cause of preventable harm and death worldwide, annually costing some $42B globally and $1.28B in Australia.
Study aims to understand why resistance occurs to Venetoclax when treating blood cancers
In Australia, there is an excess burden of stroke in regional and rural areas and patients do not have the same access to specialised care as in metropolitan areas.
Youth suicide is a growing problem in Australia that has far-reaching effects on family, friends and the community.